10 DeSci Projects Tokenizing IP for Drug Discovery in 2026

I will discuss the DeSci Projects Tokenizing IP for Drug Discovery and analyze how decentralized science platforms change biotechnology innovation.

These projects utilize blockchain technology to tokenize Intellectual Property (IP), enhance funding for research, provide transparency for ownership, and connect scientists, investors, and communities for the purpose of expediting drug discovery as well as creating new pathways in the pharmaceutical business.

What is DeSci Projects Tokenizing?

DeSci Projects Tokenization utilizes blockchain to represent scientific research, intellectual property, patents, and biomedical innovations as digital tokens. In this context, tokens allow holders the rights and privileges to ownership, license, or invest in scientific projects.

DeSci (Decentralized Science) utilizes tokenization to offer innovative and transparent research environments. In these environments, researchers, funding bodies, and the community work with and support research projects. In biomedical innovations, research projects pose boundless opportunities depending on the needs of researchers and the availability of funding.

Because of tokenization, intellectual property in this context can be managed, and the value realized in the form of breakthroughs. This system outlines the existing cumbersome processes and improves transparency, flexibility, and the speed of introducing new innovations.

Why Choose DeSci Projects Tokenizing IP for Drug Discovery

Enhanced Funding for Research

Through DeSci projects, scientists are not bound to traditional pharmaceutical funding. They gain the ability to get funded from alternative routes, such as decentralized organizations, investors, and the community.

Transparent Ownership of Intellectual Property

Tokenization allows blockchain to build an organized and trustworthy system of records for ownership, rights, and contributions in the field of science and drug development.

Accelerated Drug Discovery

Due to the network of DeSci projects, research collaborations are less tedious. This is because researchers, biotech, and investors are more connected, and thus, are able to work on drug discovery readily.

Barrier Breaks for Global Research

DeSci projects enable community participation in research and the use of research resources. This happens regardless of geographical location.

Innovative Research by the Community

DeSci allows research on medical conditions to be funded and the community to direct the research.

Novel Investment Channels

Intellectual property that has been tokenized allows participation and funding of underdeveloped biotech research.

Increased Transparency for Research

Blockchain records enable a transparent system for funding and tracking research progress and the management of intellectual property.

Research Models Centered on the Patient

DeSci projects put community patients at a higher level who are able to support research on medical challenges.

Key Point & DeSci Projects Tokenizing IP for Drug Discovery

• Molecule – Decentralized biotech platform enabling researchers to tokenize intellectual property (IP), fund drug discovery projects, and connect scientists with global investors.
• VitaDAO – Community-owned DeSci organization focused on funding longevity research and transforming biomedical research assets into tokenized intellectual property.
• LabDAO – Decentralized scientific network providing open access to laboratory tools, computational resources, and collaboration infrastructure for biotech innovation.
• BioDAO – Web3-powered biotech ecosystem that supports scientific communities in developing, funding, and managing decentralized biomedical research projects.
• GenomesDAO – Genomics-focused platform allowing individuals to control, monetize, and securely share genomic data for research and pharmaceutical development.
• PharmaDAO – Decentralized pharmaceutical research community designed to support drug discovery initiatives through collective funding and blockchain-based ownership models.
• CryoDAO – DeSci project focused on cryonics and life-extension research by enabling community-driven funding and ownership of scientific discoveries.
• PsyDAO – Decentralized research organization advancing psychedelic science by funding studies, intellectual property development, and therapeutic innovation.
• AntibodyDAO – Blockchain-based biotech initiative focused on antibody discovery, research collaboration, and tokenized ownership of scientific breakthroughs.
• RareDAO – Decentralized science community supporting rare disease research by connecting patients, researchers, and funders through shared IP ownership models.

10 DeSci Projects Tokenizing IP for Drug Discovery in 2026

1. Molecule

Molecule is a top decentralized science (DeSci) platform dedicated to the tokenization of biomedical intellectual property. It utilizes a blockchain ownership model to connect researchers, investors, and patient communities and enables funding for scientific projects.

Molecule allows researchers to mint their own IP-NFTs (Intellectual Property Non-Fungible Tokens). Molecule is one of several DeSci Projects Tokenizing IP for Drug Discovery and aims to facilitate scientific funding, offer greater transparency, and provide innovative drug development investors with additional options.

The platform develops a world market for scientific research by enabling funding and monetization of research IP.

Why Molecule Matters

Key Point	Explanation
Decentralized Research Funding	Molecule matters because it creates new funding opportunities for biotech researchers beyond traditional pharmaceutical companies and venture capital systems.
Tokenized Intellectual Property	It enables researchers to convert scientific discoveries into blockchain-based IP assets, improving ownership transparency and investment access.
Faster Drug Development	Molecule helps accelerate drug discovery by connecting scientists, investors, and communities in a decentralized ecosystem.
Global Scientific Collaboration	The platform allows researchers worldwide to collaborate and access funding for innovative biomedical projects.
Community-Based Innovation	Molecule gives patients, researchers, and investors a role in supporting and managing future medical breakthroughs.

2. VitaDAO

VitaDAO is a decentralized research collective that focuses on the science and research of biotechnology and life-extension. It is a blockchain-based funding model for early-stage biomedical research with community ownership of research IP.

VitaDAO provides a funding model that goes beyond the traditional pharmaceutical system, which not only sustains but also slows research, and enables scientists to innovate on aging and other regenerative and health technologies. Another of the DeSci Projects Tokenizing IP for Drug Discovery,

VitaDAO provides governance and ownership of scientific assets through a decentralized system and tokenomics. This model enables researchers, patients, and investors to directly engage in the creation and commercialization of innovative and disruptive medicines.

Why VitaDAO Matters

Key Point	Explanation
Supports Longevity Research	VitaDAO matters because it funds research focused on aging, life extension, and regenerative medicine.
Community Ownership Model	It enables communities to collectively own and govern biomedical research assets through decentralized systems.
Alternative Biotech Funding	VitaDAO provides researchers with new funding methods outside traditional pharmaceutical investment models.
Tokenized Research Assets	It allows scientific discoveries to be represented as digital assets with transparent ownership structures.
Accelerates Medical Innovation	VitaDAO helps bring promising longevity therapies closer to development through collaborative research efforts.

3. LabDAO

LabDAO is a decentralised science organisation that builds an open network infrastructure for scientists, labs, and biotech developers. Using decentralised systems, LabDAO provides access to computational resources, lab services, and engagement with science.

LabDAO aims to eliminate barriers that slow the pace of innovation in the traditional research ecosystem. It allows scientists to collaborate from all over the world. In the context of DeSci Projects Tokenizing IP for Drug Discovery, LabDAO helps the development and the management of research IP on the transparent blockchain.

It also brings the opportunity to researchers to collaborate on the development of biotech innovations and reinforces the principles of open science and community-based drug discovery.

Why LabDAO Matters

Key Point	Explanation
Open Scientific Infrastructure	LabDAO creates decentralized access to scientific tools, computational resources, and laboratory services.
Reduces Research Barriers	It helps smaller research teams access resources that are normally limited to large institutions.
Encourages Collaboration	LabDAO connects scientists, developers, and researchers to work together on biotechnology projects.
Supports Open Science	The platform promotes transparent research processes and shared scientific knowledge.
Improves Research Efficiency	By providing decentralized tools, LabDAO helps researchers develop discoveries faster and more effectively.

4. BioDAO

BioDAO is a decentralised biotech ecosystem that integrates blockchain and biomedical research in order to foster scientific innovation and ownership. It provides a platform for collaboration among researchers, investors, and communities to develop drug discovery projects and new funding and IP frameworks.

BioDAO’s primary focus is on developing decentralised biotech ventures where research contributors are empowered to hold ownership and governance rights.

In line with DeSci Projects Tokenizing IP for Drug Discovery, BioDAO is aimed at the rapid conversion of scientific breakthroughs into digital assets with integrated ownership. This allows for accelerated research, transparent funding, and active participation in drug development projects.

Why BioDAO Matters

Key Point	Explanation
Decentralized Biotechnology Development	BioDAO creates a community-driven model for developing and managing biotech innovations.
Shared Intellectual Property	It allows researchers and contributors to participate in ownership of scientific discoveries.
Better Research Funding	BioDAO provides decentralized funding opportunities for promising biomedical projects.
Transparent Governance	Blockchain-based decision-making improves accountability and community participation.
Supports Future Medicines	BioDAO helps create a new ecosystem for developing advanced healthcare solutions.

5. GenomesDAO

GenomesDAO is building tools for users to manage their genomic data better. Their tools give users control over their information and allow for secure collabs.

Their tools are built on blockchain tech and allow users to potentially earn rewards by sharing their data. They work with datasets and help integrate genomics with pharma and biotech to help innovate further on personalized medicine.

Among DeSci Projects Tokenizing IP for Drug Discovery, GenomesDAO uses a fresh perspective to show how genomic data can be a major resource in research. Ethical data sharing, a decentralized approach, and transparency are incorporated to encourage people to participate in medical innovations.

Why GenomesDAO Matters

Key Point	Explanation
Patient-Controlled Genetic Data	GenomesDAO matters because it allows individuals to maintain control over their genomic information.
Secure Data Sharing	It enables researchers to access genetic data through privacy-focused blockchain systems.
Supports Personalized Medicine	Genomic insights can help develop targeted treatments and personalized healthcare solutions.
Creates Data Ownership Opportunities	Users can benefit from the value generated through ethical use of their genetic data.
Improves Drug Discovery	Access to genomic information can help pharmaceutical companies develop more effective medicines.

6. PharmaDAO

PharmaDAO is a decentralized structure for improving pharma research and discovery under a collaborative model. The goal is to create a more open pharma landscape for researchers and contributors to participate in drug development.

For example, PharmaDAO is one of the emerging DeSci Projects Tokenizing IP for Drug Discovery, and is committed to the tokenization of research assets.

This model offers a decentralized approach to pharma research, connecting community members and investors, and aims to improve transparency and lessen funding obstacles in order to facilitate the development of novel therapeutics.

Why PharmaDAO Matters

Key Point	Explanation
Decentralizes Pharmaceutical Research	PharmaDAO creates an alternative model where communities can participate in drug development.
Improves IP Management	It helps manage pharmaceutical intellectual property through transparent blockchain systems.
Enables Collective Investment	Researchers and supporters can collectively fund promising medical discoveries.
Increases Transparency	Blockchain-based systems provide clearer tracking of research ownership and funding.
Supports Innovation	PharmaDAO encourages faster development of new pharmaceutical solutions.

7. CryoDAO

CryoDAO is a decentralized organization that focuses on cryonics, life extension, and biotechnology. They use decentralized funding and community governance to support researchers and innovators in the developmental stages of biotechnological advancements.

While being a part of the DeSci Projects Tokenizing IP for Drug Discovery, CryoDAO helps demonstrate how ownership models that use blockchain can sustain dedicated research in biotechnology.

Their project lets a community self-manage the funding of research and the governance of scientific assets. This leads to the potential for groundbreaking work to be done in medical science.

Why CryoDAO Matters

Key Point	Explanation
Advances Cryonics Research	CryoDAO supports scientific exploration in cryonics and life-extension technologies.
Community-Driven Funding	It enables communities to support specialized scientific research projects.
Encourages Long-Term Innovation	CryoDAO focuses on emerging technologies that may impact future healthcare.
Decentralized Research Ownership	Blockchain models allow contributors to participate in scientific asset ownership.
Expands DeSci Applications	CryoDAO demonstrates how decentralized science can support niche research fields.

8. PsyDAO

PsyDAO is a decentralized research organization that specializes in psychedelic science, mental health, and therapeutics. PsyDAO helps to stimulate the innovation in treatment of psychedelics by uniting scientists, researchers, and the funding community.

PsyDAO uses decentralized governance to help fund research and create new ownership laws of scientific discoveries. While being a part of the DeSci Projects Tokenizing IP for Drug Discovery, PsyDAO is dedicated to finding ways blockchains can be used to tokenize the intellectual properties of psychedelic medicine and biotechnology.

The model promotes collaboration and transparent funding along with an ownership system for the research results to help speed the process of developing innovative therapies for the treatment of mental health.

Why PsyDAO Matters

Key Point	Explanation
Supports Psychedelic Research	PsyDAO helps fund research into psychedelic-based therapies and medical applications.
Improves Mental Healthcare Innovation	It supports the development of new treatments for neurological and psychological conditions.
Decentralized Research Funding	PsyDAO provides alternative funding models for scientific studies.
Community Participation	Researchers, patients, and investors can contribute to research decisions.
Tokenized Scientific Assets	It enables intellectual property related to psychedelic research to be managed through decentralized systems.

9. AntibodyDAO

AntibodyDAO is a decentralized biotech project that seeks to create antibodies and therapeutics and promote cross-disciplinary science. Antibody researchers play an important role in cancer and infectious disease treatment, as well as the design of therapeutics.

AntibodyDAO employs decentralized methods to recruit and bind researchers and curious communities and investors to the potential of antibodies. Because it is one of the DeSci Projects Tokenizing IP for Drug Discovery, AntibodyDAO allows the scientific IPs to be bound through the blockchain system of ownership.

It potentially enhances the funding for the projects, the collaboration of researchers, and the multiple ways of engaging the products of antibodies within the biotech industry.

Why AntibodyDAO Matters

Key Point	Explanation
Advances Antibody Discovery	AntibodyDAO supports research into antibody-based medicines and therapies.
Accelerates Biotechnology Innovation	It helps researchers develop solutions for diseases such as cancer and infections.
Enables Research Collaboration	Scientists and communities can work together through decentralized networks.
Supports IP Tokenization	It creates new methods for managing ownership of antibody discoveries.
Improves Drug Development	AntibodyDAO helps increase access to funding and resources for therapeutic research.

10. RareDAO

RareDAO is a decentralized platform for science that is designed to promote research on rare diseases and unify patients and the biotech research community.

Typical rare disease research is often unfunded due to a small patient population, but RareDAO is designed to tackle this problem using a decentralized model of shared ownership. The platform provides communities the means to support research, control scientific resources and foster patient-centered research.

As a participant of the DeSci Projects Tokenizing IP for Drug Discovery, RareDAO is making efforts to simplify funding and IP through blockchain technology and thus, make rare disease research easier to pursue.

Why RareDAO Matters

Key Point	Explanation
Supports Rare Disease Research	RareDAO helps address funding challenges faced by rare disease studies.
Gives Patients a Voice	It allows patient communities to participate directly in research development.
Improves Research Funding Access	Decentralized models help attract support for overlooked medical conditions.
Enables Shared IP Ownership	RareDAO creates transparent systems for managing research discoveries.
Accelerates Rare Disease Treatments	It helps connect researchers, patients, and investors to develop new therapies faster.

Conclusion

DeSci Projects Tokenizing IP for Drug Discovery merge Blockchain technology and biotechnology to formulate a decentralized funding model that innovates ownership and transparency of IP.

With projects like Molecule, VitaDAO, and LabDAO, researchers, investors, and communities are afforded the opportunity to participate in shared ownership as a means to collaborate on medical discoveries.

DeSci participants are tokenizing scientific discoveries, improving accessibility for funding, increasing research transparency, and eliminating barriers to the development of pharmaceuticals and therapeutics.

With the continued expansion of decentralized science, the IP tokenization of DeSci Projects will likely transform the drug discovery process, and cultivate a healthcare ecosystem that is more open and cooperative.

FAQ